Correction to: Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F -induced myeloproliferative neoplasms.

Mengshi HuTao YangLinyu YangLu NiuJinbing ZhuAilin ZhaoMingsong ShiXue YuanMinghai TangJianhong YangHeying PeiZhuang YangQiang ChenHaoyu YeTing Niu Li-Juan Chen

Published in: Blood cancer journal (2024)

Keyphrases

acute myeloid leukemia
high glucose
diabetic rats
tyrosine kinase
cell therapy
stem cells
drug induced
oxidative stress
mesenchymal stem cells